Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States: Jagsi R, Jiang J, Momoh AO, et al (Univ of Michigan, Ann Arbor; The Univ of Texas MD Anderson Cancer Ctr, Houston; Et al) J Clin Oncol 32:919-926, 2014

Purpose. -Concerns exist regarding breast cancer patient's access to breast reconstruction, which provides important psychosocial benefits. Patients and Methods. -Using the MarketScan database, a claims-based data set of US patients with employment- based insurance, we identified 20,560 women undergoing mastectomy for breast cancer from 1998 to 2007. We evaluated time trends using the Cochran-Armitage test and correlated reconstruction use with plastic-surgery workforce density and other treatments using multivariable regression. Results. -Median age of our sample was 51 years. Reconstruction use increased from 46% in 1998 to 63% in 2007 (P <001), with increased use of implants and decreased use of autologous techniques over time (P <001). Receipt of bilateral mastectomy also increased: from 3% in 1998 to 18% in 2007 (P <001). Patients receiving bilateral mastectomy were more likely to receive reconstruction (odds ratio [OR], 2.3; P <001) and patients receiving radiation were less likely to recive reconstruction (OR, 0.44; P <001). Rates of reconstruction receipt varied dramatically by geographic region, with associations with plastic surgeon density in each state and county-level income. Autologous techniques were more often used in patients who received both reconstruction and radiation (OR, 1.8; P <001) and less frequently used in patients with capitated insurance (OR, 0.7; P <001), patients undergoing bilateral mastectomy (OR, 0.5; P <001), or patients in the highest income quartile (OR, 0.7; P 1/4006). Delayed reconstruction was performed in 21% of patients who underwent reconstruction. Conclusion. -Breast reconstruction has increased over time, but it has wide geographic variability. Receipt of other treatments correlates with the use of and approaches toward reconstruction. Further research and interventions are needed to ensure equitable access to this important component of multidisciplinary treatment of breast cancer.